Price Alert

Catalyst Pharmaceuticals ... (CPRX)

NASDAQ: CPRX · Real-Time Price · USD

20.23

0.16 (0.80%)

At close: Aug 15, 2025, 3:59 PM

20.15

-0.37%

After-hours: Aug 15, 2025, 07:54 PM EDT

Catalyst Pharmaceuticals Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021
Period Ending	Jun 30, 2025	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021
Revenue	146.56M	141.42M	141.82M	128.69M	122.71M	98.51M	110.57M	102.69M	99.58M	85.37M	60.76M	57.24M	53.11M	43.09M	38.31M	35.95M	36.37M	30.2M
Cost of Revenue	29.96M	17.91M	21.64M	19.28M	24.75M	12.52M	24.87M	14.17M	12.04M	9.95M	11.2M	9.66M	7.64M	5.89M	7.35M	5.31M	4.54M	4.68M
Gross Profit	116.61M	123.51M	120.18M	109.42M	97.96M	85.99M	85.7M	88.52M	87.54M	75.42M	49.56M	47.58M	45.47M	37.2M	30.96M	30.64M	31.82M	25.52M
Operating Income	66.3M	63.37M	62.84M	50.91M	54.25M	27.13M	41.69M	-37.19M	46.7M	35.61M	30.8M	25.1M	28.57M	17.37M	12.74M	14M	15.84M	9.8M
Interest Income	5.95M	5.28M	n/a	n/a	n/a	n/a	n/a	n/a	1.81M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Pretax Income	69.29M	71.29M	74.18M	57.2M	55.79M	29.09M	46.71M	-38.02M	48.51M	37.31M	33.01M	26.01M	28.25M	17.46M	12.81M	14.07M	15.9M	9.88M
Net Income	52.11M	56.74M	55.94M	43.88M	40.79M	23.27M	34.84M	-30.76M	37.76M	29.57M	25.47M	22.75M	21.62M	13.24M	9.31M	10.33M	12.18M	7.66M
Selling & General & Admin	45.95M	46.91M	44.19M	45.88M	40.73M	46.94M	42.04M	33.56M	28.4M	29.72M	14.67M	13.65M	12.92M	16.43M	13.23M	12.15M	11.53M	12.72M
Research & Development	4.36M	3.89M	3.8M	3.28M	2.98M	2.58M	1.97M	83.66M	3.95M	3.56M	4.09M	8.31M	3.98M	3.4M	4.99M	4.49M	4.45M	3.01M
Other Expenses	n/a	9.35M	9.34M	9.35M	n/a	1.96M	n/a	-833K	1.81M	6.53M	n/a	905K	n/a	93K	71K	68K	62K	81K
Operating Expenses	50.31M	60.14M	47.99M	58.51M	43.72M	58.86M	44.01M	125.71M	40.84M	39.81M	18.76M	22.48M	16.9M	19.83M	18.22M	16.64M	15.98M	15.72M
Interest Expense	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	324K	n/a	n/a	n/a	n/a	n/a
Selling & Marketing Expenses	n/a	2.6M	2.4M	2.5M	26.25M	25.32M	28.93M	21.68M	18.31M	17.76M	7.83M	7.58M	7.27M	6.79M	7.97M	6.52M	5.98M	5.68M
Cost & Expenses	80.27M	78.05M	78.98M	77.79M	68.46M	71.38M	68.88M	139.88M	52.88M	49.76M	29.96M	32.14M	24.54M	25.72M	25.57M	21.95M	20.53M	20.4M
Income Tax Expense	17.18M	14.55M	18.25M	13.32M	14.99M	5.81M	11.86M	-7.26M	10.75M	7.75M	7.54M	3.26M	6.63M	4.22M	3.5M	3.74M	3.72M	2.22M
Shares Outstanding (Basic)	122.16M	121.47M	119.89M	118.93M	118.18M	116.81M	106.71M	106.57M	106.26M	105.56M	104.58M	103.32M	108.09M	109.04M	103.11M	103.2M	103.41M	103.81M
Shares Outstanding (Diluted)	127.54M	126.96M	126.28M	125.41M	124.66M	123.4M	113.76M	106.57M	113.67M	113.99M	113.53M	111.99M	109.26M	109.04M	108.96M	107.84M	107.73M	106.68M
EPS (Basic)	0.43	0.47	0.47	0.37	0.35	0.20	0.33	-0.29	0.36	0.28	0.24	0.22	0.20	0.12	0.09	0.10	0.12	0.07
EPS (Diluted)	0.41	0.45	0.44	0.35	0.33	0.19	0.31	-0.29	0.33	0.26	0.22	0.20	0.20	0.12	0.09	0.10	0.11	0.07
EBITDA	78.75M	72.83M	72.3M	50.91M	54.25M	36.56M	50.84M	-28.62M	55.27M	35.61M	33.69M	25.66M	28.61M	17.4M	12.92M	14.04M	15.87M	9.9M
EBIT	69.29M	63.37M	62.84M	50.91M	55.79M	29.09M	46.71M	-37.19M	48.51M	37.31M	33.01M	26.01M	28.25M	17.46M	12.81M	14.07M	15.9M	9.88M
Depreciation & Amortization	9.46M	9.46M	9.53M	n/a	9.5M	9.5M	9.14M	8.63M	8.63M	6.66M	678K	553K	99K	94K	109K	139K	139K	97K